riociguat brands

3 registered brands containing riociguat in Kenya.

Molecular formula: C20H19FN8O2

Riociguat is a stimulator of soluble guanylate cyclase (sGC), an enzyme in the cardiopulmonary system and the receptor for nitric oxide (NO). When NO binds to sGC, the enzyme catalyzes synthesis of the signaling molecule cyclic guanosine monophosphate (cGMP). Intracellular cGMP plays an important role in regulating processes that influence vascular tone, proliferation, fibrosis and inflammation. Pulmonary hypertension is associated with endothelial dysfunction, impaired synthesis of nitric oxide and insufficient stimulation of the NO-sGC-cGMP pathway. Riociguat has a dual mode of action. It sensitizes sGC to endogenous NO by stabilizing the NO-sGC binding. Riociguat also directly stimulates sGC via a different binding site, independently of NO. Riociguat stimulates the NO-sGC-cGMP pathway and leads to increased generation of cGMP with subsequent vasodilation.

Source: PubChem (NCBI) ยท compound 11304743

Product Manufacturer Status Country
RIOCI 0.5
0.5 MG
Simba Pharmaceuticals Registered Kenya
RIOCI 1
1 MG
Simba Pharmaceuticals Registered Kenya
RIOCI 1.5
1.5 MG
Simba Pharmaceuticals Registered Kenya